Longevity & Anti-senescence Therapy Market: Introduction
Aging is characterized by a progression in losing of physiological integrity and function over time. Aging epigenetics refers to changes in gene expression that naturally occur during an organismal lifespan without altering the DNA sequence. Chromatin epigenetics is regulated by several enzymes, which collectively give rise to modifications in DNA methylation and histone methylation/acetylation processes. During aging, chromatin appears to be in a more active state, with an overall decrease in DNA methylation, thus leading to more relaxed global gene expression. Senescent cells are linked with many age-related diseases such as neurodegenerative diseases (Alzheimer’s and Parkinson’s disease; AD and PD, respectively), cataract, glaucoma, cardiovascular diseases (CVD, atherosclerosis, and hypertension), chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), diabetes type II, sarcopenia, osteoarthritis, osteoporosis, and certain types of tumors. The development of science and medicine has contributed to the increase in human lifespan. However, with increase in life expectancy, an increase in incidence of age-related diseases has been observed. Therefore, it is crucial to find an approach to prevent or delay ageing and the onset of age-related diseases. The only non-genetic approach that can extend longevity is dietary/calorie restriction (DR/CR). This intervention involves a 20% to 40% reduction in calorie intake without causing malnutrition and has been shown to be effective in several species including yeast, fruit flies, nematodes, rats, dogs, and even primates.
Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Longevity & Anti-senescence Therapy Market Report
Key Drivers of Global Longevity & Anti-senescence Therapy Market
Increase in Geriatric Population Worldwide
The world’s geriatric population continues to grow at an unprecedented rate. Today, 8.5% of people worldwide (617 million) are aged 65 and over. According to a new report – ‘An Aging World: 2015’, the percentage is projected to jump to nearly 17% of the world’s population by 2050 (1.6 billion). According to the National Institutes of Health, America’s 65-and-over population is projected to nearly double over the next three decades, from 48 million to 88 million by 2050. The global population of the people aged 80 and older is expected to more than triple between 2015 and 2050, growing from 126.5 million to 446.6 million. The population aged 80 and above in some countries in Asia and Latin America is predicted to quadruple by 2050.
Rise in Awareness of Antiaging Products among Generation Y and Later Generations
Anti-wrinkle products are gaining traction as they have formulation well suited to slower the aging process. Major causes of wrinkles include the lack of essential nutrients in the body, exposure to UV light and pollution for higher duration, smoking, dehydration, and drugs, along with other genetic factors. Greater aging anxiety and higher importance of appearance were related to greater likelihood of purchasing anti-aging products.
North America to Hold Major Share of Global Longevity & Anti-senescence Therapy Market
- North America is expected to hold major share of the global longevity & anti-senescence therapy market during the forecast period. The market in North America is estimated to expand at a rapid pace in the near future, primarily, due to structured reimbursement policies, increase in prevalence of obesity & cardiovascular diseases, developed health care infrastructure, and continuous research activities in developing advanced technologies in North America.
- The longevity & anti-senescence therapy market in Asia Pacific is projected to expand at a rapid pace during the forecast period. This can be attributed to growing trend of preventive health care measures in North America.
Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Longevity & Anti-senescence Therapy Market Report
Key Players Operating in Global Market
The global longevity & anti-senescence therapy market is highly concentrated, due to strong presence of a few key players. Several manufacturers hold major share in the market in their respective regions. Leading players operating in the global longevity & anti-senescence therapy market are:
- Acorda Therapeutics
- Calico Life Sciences
- Human Longevity Inc.
- Insilico Medicine
- Oisin Biotechnology
- Proteostasis Therapeutics Inc.
- Recursion Pharmaceuticals
- Senex Biotechnology
- Senolytic Therapeutics
- Sierra Sciences LLC
Global Longevity & Anti-senescence Therapy Market: Research Scope
Global Longevity & Anti-senescence Therapy Market, by Therapy
- Senolytic Drug Therapy
- Gene Therapy
Global Longevity & Anti-senescence Therapy Market, by Application
- Senescence Inhibition
- Cardiovascular Diseases
- Neural Degenerative Diseases
- Ophthalmology Disorders
Global Longevity & Anti-senescence Therapy Market, by Region
- North America
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.